ETFs
C
COR
Cencora Inc.
327.56
+5.19+1.61%After Hours: 326.50 -1.06 -0.32%17:48 04/17 EDT
OPEN/PREV CLOSE321.81/323.01
TODAY RANGE311.88-321.88
VOL1.48M
MARKET CAP60.77B
52 WEEK RANGE269.07-376.92
AVG VOL (3M)1.36M
% TURNOVER0.76%
TURNOVER--
P/E (TTM)37.58
% RANGE3.09%
EPS(TTM)8.31
P/E(FORWARD)21.62
P/B31.84
BVPS9.81
DIVIDEND2.400
P/S0.1886
BETA--
DIV YIELD0.77%
FREE FLOAT MKT CAP58.19B
SHARES OUTSTANDING194.53M
NEXT EARNINGS05/05-05/11
FREE FLOAT186.27M
LOT SIZE1
EX-DATE02/13/2026
News
Press Releases
Financial Reports
Profile
TipRanks·04/13 10:58
Wells Fargo Issues a Buy Rating on Cencora (COR)
Seeking Alpha·04/12 06:08
All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside
Seeking Alpha·03/31 12:20
Marvell jumps as Nvidia invests $2B; companies announce strategic partnership
Seeking Alpha·03/24 11:04
Cencora to buy EyeSouth Partners’ retina business for $1.1B
TipRanks·03/23 12:00
Cencora to Acquire EyeSouth Retina Business for Expansion
TipRanks·03/23 11:05
Cencora signs agreement to acquire EyeSouth Partners’ retina business for $1.1B
Seeking Alpha·03/22 13:05
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Novartis in focus
TipRanks·03/18 10:45
Wells Fargo Keeps Their Buy Rating on Cencora (COR)
TipRanks·03/18 06:05
Barclays Sticks to Their Buy Rating for Cencora (COR)
TipRanks·03/17 15:51
Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
TipRanks·03/17 13:28
Cencora CFO Retirement Announced, Financial Guidance Reaffirmed
TipRanks·03/17 13:21
Cencora CFO James Cleary to retire
TipRanks·03/17 13:21
Cencora backs FY26 adjusted EPS view $17.45-$17.75, consensus $17.62
Same Industry
Name/Symbol
Change%
Price